Following a very successful collaboration, the parties are in active commercial discussions to pursue joint commercialization of the solutionNess ...

Abstract: Relatively small data sets available for expression recognition research make the training of deep networks very challenging. Although fine-tuning can partially alleviate the issue, the ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today provided a corporate update and reported ...